================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                            ------------------------

                                  SCHEDULE 13D
                    UNDER THE SECURITIES EXCHANGE ACT OF 1934


                         HUMAN PHEROMONE SCIENCES, INC.
                                (Name of Issuer)


                                  COMMON STOCK
                         (Title of Class of Securities)


                                    44485Q203
                                 (CUSIP Number)


                          RENOVATIO GLOBAL FUNDS, L.P.
                    2221 OLD OAKLAND ROAD, SAN JOSE, CA 95131
                                 (408) 456-0982
           (Name, Address and Telephone Number of Person Authorized to
                       Receive Notices and Communications)


                                 MARCH 10, 2006

             (Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box
[ ].

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).


================================================================================



         CUSIP No. 44485Q203

- --------------------------------------------------------------------------------
1.   Name of Reporting Persons.
     I.R.S. Identification Nos. of above persons (entities only).
     Renovatio Global Funds, L.P. - 20-3889119
- --------------------------------------------------------------------------------
2.   Check the Appropriate Box If a Member of a Group (See Instructions)
     (a)  [_]
     (b)  [_]
- --------------------------------------------------------------------------------
3.   SEC Use Only

- --------------------------------------------------------------------------------
4.   Source of Funds (See Instructions)
     OO
- --------------------------------------------------------------------------------
5.   Check If Disclosure of Legal Proceedings Is Required Pursuant to
     Items 2(d) or 2(e)                                             [_]

- --------------------------------------------------------------------------------
6.   Citizenship or Place of Organization
     California
- --------------------------------------------------------------------------------
               7.   Sole Voting Power
  NUMBER OF         657,723
   SHARES      -----------------------------------------------------------------
BENEFICIALLY   8.   Shared Voting Power
 OWNED BY           None
    EACH       -----------------------------------------------------------------
  REPORTING    9.   Sole Dispositive Power
   PERSON           657,723
    WITH       -----------------------------------------------------------------
               10.  Shared Dispositive Power
                    None
- --------------------------------------------------------------------------------
11.  Aggregate Amount Beneficially Owned by Each Reporting Person
     657,723
- --------------------------------------------------------------------------------
12.  Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares
     (See Instructions)                                               [_]
- --------------------------------------------------------------------------------
13.  Percent of Class Represented by Amount in Row (11)
     15.8%
- --------------------------------------------------------------------------------
14.  Type of Reporting Person (See Instructions)
     Limited Partnership
- --------------------------------------------------------------------------------







ITEM 1. SECURITY AND ISSUER

         The title of the class of equity securities to which this statement
relates is Common Stock ("Issuer Common Stock") of Human Pheromone Sciences,
Inc., a California corporation (the "Issuer"). The principal executive offices
of the Issuer are located at 84 West Santa Clara Street, Suite 720, San Jose, CA
95113.

ITEM 2. IDENTITY AND BACKGROUND.

         (a) The name of the entity filing this statement is Renovatio Global
Funds, L.P., hereinafter sometimes referred to as the "Reporting Person."

         (b) The principal business address and the principal office of the
Reporting Person is: 2221 Old Oakland Road, San Jose, CA 95113.

         (c) The Reporting Person's principal occupation or employment is
investment, with a business address at 2221 Old Oakland Road, San Jose, CA
95113.

         (d) During the last five years, the Reporting Person has not been
convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors).

         (e) During the last five years, the Reporting Person has not been a
party to a civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a judgment,
decree or final order enjoining future violations of, or prohibiting or
mandating activities subject to, United States Federal or State securities laws
or finding any violations with respect to such laws.

         (f) United States of America

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

         The Reporting Person acquired 657,723 shares of Issuer Common Stock on
March 10, 2006 for an aggregate consideration of $328,861.50 in cash.

ITEM 4. PURPOSE OF TRANSACTION.

         The Reporting Person acquired the Issuer Common Stock held by it for
investment purposes in connection with the Agreement described in Item 3.



         Except as described in this Item 4, the Reporting Person has no plans
or proposals that would result in any of the transactions described in items (a)
through (j) of Item 4 of Schedule 13D.

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.

         (a)      See Rows 11 and 13 of the Cover Page.

         (b)      See Rows 7 through 10 of the Cover Page.

         (c) During the past sixty days, the only transactions by the Reporting
Person involving the Issuer's Common Stock are described in Item 3 above.

         (d) To the best knowledge of the Reporting Person, no other person has
the right to receive, or the power to direct the receipt of, dividends from, or
the proceeds from the sale of, the shares of Issuer Common Stock reported in
Item 5(a).

         (e) Not applicable.


ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
        SECURITIES OF THE ISSUER.

         The information set forth in Items 3 and 4 of this Schedule 13D is
incorporated herein by reference.

ITEM 7. MATERIALS TO BE FILED AS EXHIBITS.

         None.




================================================================================


                                    SIGNATURE

         After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

REPORTING PERSON:                          RENOVATIO GLOBAL FUNDS, L.P.



Date: March 14, 2006                       By: /s/ Steven Yao
                                               ---------------------------------
                                               Name: Steven Yao, CFO of Dubuglo,
                                               LLC General Partner